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The interactions between a novel enediyne [1-methyl-2-(phenylethynyl)-3-(3-phenylprop-2-
ynyl)-3H-benzimidazolium] (1) and various cytosine-containing oligonucleotides were studied
using electrospray ionization mass spectrometry (ESI-MS) in a flow injection analysis mode
useful for small volumes. This enediyne ligand, developed as a potential alternative to the
highly cytotoxic natural enediynes, some of which have been successfully used as anti-tumor
agents, has previously been shown to interact with DNA through frank strand scission as well
as via the formation of adducts that lead to 2=-deoxycytidine-specific cleavage. Through
ESI-MS, the structures of these adducts were examined and a sequence dependence of the
2=-deoxycytidine-specific cleavage was noted. Collisionally activated dissociation of the
observed adducts confirmed the strength of the interactions between the enediyne and DNA
and supports a direct linkage between the enediyne and the cytosine nucleobase, likely the
result of a nucleophilic attack of the phenylethynyl group by the cytosine amine. (J Am Soc
Mass Spectrom 2006, 17, 1342–1352) © 2006 American Society for Mass SpectrometryFollowing the initial elucidation of the structure ofthe neocarzinostatin chromophore [1], much ef-fort has been directed towards identifying addi-
tional natural enediynes and evaluating their activities
[2–5]. Currently, nearly twenty of these natural
enediynes have been identified, including calichemicin
1
I [6, 7], dynemicin [8], and the esperamicins [9, 10].
While these enediynes offer extremely high cytotoxic
activities, their clinical use as anti-tumor agents has
been limited due to their delayed activities and general
toxicity [2–5].
To overcome the shortcomings of these natural
enediynes, a range of synthetic analogs have been
explored [3, 11], each with the goal of improved prop-
erties for clinical use. While still capable of cleaving
DNA like the natural products through cycloaromati-
zation reactions and subsequent hydride abstraction by
the diradical intermediate [2– 4, 11, 12], these analogs
offer potential advantages, such as more controlled
activation of the compound in vivo [13–23] or increased
selectivity for tumor cells [24 –30].
To better evaluate the activities and properties of the
many enediyne drug candidates as well as various
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technique for analyzing the interactions between these
compounds and DNA using a flow injection analysis
(FIA) mode coupled to an electrospray ionization mass
spectrometer (ESI-MS). This analysis offers several key
advantages over the traditional gel-based electro-
phoretic techniques. First, the dramatically better reso-
lution of mass spectrometry versus polyacrylamide gel
electrophoresis (PAGE) allows differentiation of simi-
larly sized species, enabling the detection of very small
molecules adducted to DNA. Second, while gel electro-
phoresis typically requires micrograms of sample, with
our FIA method, a mass spectrum can easily be col-
lected with nanograms, a sensitivity advantage of up to
three orders of magnitude. Lastly, FIA-ESI-MS is easily
adaptable to high-throughput analyses [31–33].
In recent years, applications of ESI-MS for DNA
analysis have begun to mature [34, 35]. A critical
component of many of these experiments is the appli-
cation of tandem mass spectrometry to probe the frag-
ments produced when DNA ions [34 –36], noncovalent
DNA-drug complexes [37, 38], or covalent DNA-drug
complexes [39 –55] are energized in the gas phase.
Collisionally-activated dissociation (CAD) [56], infrared
multiphoton dissociation (IRMPD) [57, 58], and electron
capture dissociation (ECD) [59] have all been demon-
strated to yield useful information about oligonucleo-
tides. With respect to covalently bound DNA adducts,
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of both the position and mode of attachment of a drug
or ligand to a DNA sequence has been the primary
focus of many of these prior reports [39 –55]. Despite the
potential advantages in applying ESI-MS to the study of
enediyne-DNA interactions, we have found no reports
exploring this method.
Previous studies have shown that 1 (Structure 1)
interacts with DNA in at least three ways: via frank
strand scission and the formation of at least two differ-
ent adducts [29]. One of these adducts subsequently
effects specific cleavage of the oligonucleotide sequence
at 2=-deoxycytidine residues [29], likely through a mode
of action very different from the radical-induced cleav-
ages commonly observed with enediyne drugs [2–5]. It
has been proposed that the adduct results from a
nucleophilic attack of one of the alkynes on the
enediyne by the DNA [28]. The gel electrophoresis
experiments used in the discovery of this behavior
lacked both the mass resolution to accurately character-
ize the adducts and the ability to further probe the
structures of the adducts. NMR methods, which would
offer substantial structural information about the ad-
ducts, are not sufficiently sensitive for analysis of the
minute quantities of adducts formed from the reactions
described herein. In this study, we present an examina-
tion of these adducts by ESI-MS. In addition to confirm-
ing the information previously obtained by gel electro-
phoresis, the mass spectrometric analysis reveals the
identity and stoichiometry of the adducts. Furthermore,
through tandem MS experiments, a series of clues
obtained about the structure of the adduct has helped to
identify both the location and mechanism of attachment
to the oligonucleotide structure.
Experimental
Reagents
The oligonucleotides and primers were synthesized on
a PerSeptive Biosystems Expedite 8909 DNA synthe-
sizer (Framingham, MA) and purified by reversed-
phase chromatography. Concentrations were deter-
mined by UV absorption at 260 nm. The enediyne, 1,
and a version that was 13C-labeled at position 1 were
prepared according to previously published proce-
N
N
CF3SO3
-
1
1
Structure 1dures [27].Preparation of Samples for Analysis
Mixtures of the different oligonucleotides at 360 M
with 3.6 mM 1 were prepared in a 10 M sodium
phosphate buffer at either pH 6 or 8 also containing 8%
DMSO (Sigma-Aldrich Corp., St. Louis, MO). These
mixtures were then incubated at 37 °C for 20 h (dCC) or
24 h (other oligonucleotides). Following incubation, the
samples were desalted either by reversed-phase HPLC
(dCC) or with C18 Waters (Midford, MA) Sep-Pak
cartridges (other oligonucleotides). Samples were fur-
ther purified using C18 ZipTips (Millipore, Bedford,
MA) immediately before analysis. Additionally, sam-
ples with dCC were prepared identically with a version
of 1 containing a 13C isotopic label at carbon one of the
phenylethynyl group to assist in identification of frag-
ment ions. Another series of dCC  1 or dGA  1
samples were incubated as above and then heated to
90 °C in the presence of 10% piperidine. The samples
were dried and resuspended in 80:20 water/methanol.
As above, the hot piperidine treated samples were
purified with C18 ZipTips.
Methods and Instrumentation
Prepared samples were analyzed on a ThermoFinnigan
LCQ Duo quadrupole ion trap mass spectrometer
equipped with the standard ESI source (San Jose, CA).
Injections of 1–5 L for the FIA were made with a
Waters Alliance 2690 Separations Module with a carrier
flow of A.C.S. grade spectranalyzed methanol (Fisher
Scientific, Fair Lawn, NJ) at 10 L/min. Mass spectra
were obtained by integrating the signal across the FIA
peak. Direct infusion experiments involving the sam-
ples of dCC  1 after hot piperidine treatment were
carried out by diluting 5 l of sample in 250 l of 50:50
water:methanol with similar electrospray conditions to
the FIA introduced samples. Nomenclature for identi-
fying oligonucleotide fragments followed the conven-
tions set forth by McLuckey et al. [36]
Results and Discussion
Interactions Between 1 and dC8
Armed with the previous results indicating that 2=-
deoxycytidine-specific cleavage of the oligonucleotide-1
adduct was observed on heat treatment with piperidine
[28, 29], interactions between the enediyne and an all
2=-deoxycytidine oligonucleotide, dC8, were examined
to determine whether or not the adducts could be
isolated and studied. The mass spectrum obtained by
FIA-ESI-MS analysis of a mixture incubated at pH 8
revealed many ions containing dC8, most of which also
contained up to three molecules of 1 per oligonucleotide
(Figure 1a). Although the wide range of adducts formed
indicated that 1 readily bound the 2=-deoxycytidine-rich
oligonucleotide under these conditions and provided
confirmation that ESI-MS could be used to detect the
ith 1
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about the mode of binding. Clearly, the sequence ho-
mogeneity precluded formation of one specific adduct
structure and, thus, oligonucleotides containing a single
2=-deoxycytidine were used for more detailed structural
studies, as described below.
Interactions Between 1 and Either dCT5 or dT2CT3
Having established that 1 readily attaches to 2=-
deoxycytidine-containing oligonucleotides, we ana-
lyzed its interactions with two different sequences
containing a single cytosine base. Previous studies
indicated that DNA cleavage was observed on heat
treatment with piperidine following incubation at
higher pH values [28]. The ESI mass spectra of oligo-
nucleotide/1 mixtures incubated at pH 8 and pH 6
yielded similar product ions. For instance, ESI-MS of
the dCT5/1 mixture incubated at pH 8 (Figure 1b)
primarily yielded several dT5 ions where cleavage oc-
curred at the POO bond 5= to the 2=-deoxythymine
adjacent to the 2=-deoxycytidine. These ions had various
charges, and several incorporated 1. The only ion from
this spectrum absent in the ESI mass spectrum obtained
for analogous mixture incubated at pH 6 (Figure 1c)
corresponded to the CF3SO3
 counter-ion. Since the S/N
of both of these mass spectra were modest due to the
low concentrations and the minimal volumes of sample
used for the FIA, our analysis focuses on the results for
Figure 1. Mass spectra of 1 incubated with o
incubated with 1 at pH 8; (c) dCT5 incubated wthe samples incubated at pH 6 because of the larger ionabundances and the greater numbers of ions observed.
Whenever possible, CAD spectra were collected for the
various adducts observed at both pH values, and the
fragmentation patterns revealed no significant discrep-
ancies.
FIA-ESI-MS analysis of the mixture of dCT5 and 1
incubated at pH 6 yielded an assortment of product
ions containing 1 (Figure 1c), and many of these prod-
ucts correspond to cleaved fragments of the oligonucle-
otide. In particular, several dT5 products, both alone
and with one or two molecules of 1, were observed. The
array of dT5 products results from cleavage on the 3=
side of the 2=-deoxycytidine of the dCT5 oligonucleotide
and provide striking evidence for the expected heat-
induced cleavage observed previously for this com-
pound [28, 29]. The selectivity for cleavage specific to
the 2=-deoxycytidine position is remarkable. In addition
to the dT5 products in Figure 1c, two adducts of the
intact dCT5 oligonucleotide, (dCT5  4·H  1)
3 at 697
Th and (dCT5  5·H  2·1  MeOH)
3 at 822 Th, were
observed along with two ions, at 749 and 1791 Th, for
which formulas could not be assigned, but dissociated
to yield fragments indicating the presence of both dCT5
and 1 (see below).
The product ions from Figure 1c with sufficient
abundance, dT5
3 at 485 Th, (dT5 1)
3 at 600 Th, (dCT5
 4·H  1)3 at 697 Th, 749 Th, (dCT5  5·H  2·1 
MeOH)3 at 822 Th, (dT5 1)
2 at 901 Th, (dT5 2·1)
2
at 1074 Th, and 1791 Th, were isolated and subjected to
ucleotides. (a) dC8 incubated with 1; (b) dCT5
at pH 6; (d) dT2CT3 incubated with 1 at pH 6.ligonCAD. The resulting CAD mass spectra (Figure 2) reveal
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and backbone cleavages typical of CAD of oligonucle-
Figure 2. CAD of ions isolated from the mass sp
were (a) dT5
3 at 485 Th, (b) (dT5 1)
3 at 600 Th
 5·H  2·1 MeOH)3 at 822 Th, (f) (dT5  1)
2
Th.otides [36]. For the related dT5 parent ions (Figure 2a, b,f, and g), whenever the parent also contained 1, one
dominant fragmentation pathway was ejection of 1,
m of dCT5 incubated with 1 at pH 6. Parent ions
CT5 4·H 1)
3 at 697 Th, (d) 749 Th, (e) (dCT5
01 Th, (g) (dT5  2·1)
2 at 1074 Th, and (h) 1791ectru
, c) (d
 at 9suggesting the molecule of 1 was only weakly attached
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deoxythymine residues. Of the backbone fragments
observed, both w ions and (dT5  w  base) ions,
analogs to the (a  base) fragment ions typically pro-
duced upon activation of intact oligonucleotide ions,
were observed. The fragmentation patterns of the (dT5
 1)2 (Figure 2f) and (dT5  2·1)
2 ions (Figure 2g) are
especially interesting because a variety of wn and (wn
1) fragment ions are observed, indicating that 1 likely
can attach to any of the 2=-deoxythymine residues.
The striking prevalence of 3= fragments in the CAD
spectra of intact (dCT5  4·H  1)
3 and (dCT5  5·H 
2·1  MeOH)3 ions is also noteworthy (Figure 2c and e).
Although complementary fragments are typically ob-
served, in these experiments w ions dominated the array
of fragments while corresponding (a  base) fragments
were not observed. This may indicate localization of the
positively-charged 1 on the 5= 2=-deoxycytidine, preclud-
ing the formation of negatively-charged (a  base) frag-
ments. Lastly, CAD of the products at 749 and 1791 Th
with unassigned molecular formulas (Figure 2d and h)
yielded fragments similar to those observedwith the other
parent ions, suggestive that these parents contained the
intact dCT5 oligonucleotide, some number of 1, and some
other unidentified species (such as counter-ions or solvent
molecules).
Similar ESI-MS/MS analysis of the products obtained
upon incubation of 1 with dT2CT3 yielded somewhat
different results. In this case, except for aweakly abundant
w2 adduct observed in the pH 8 spectrum (data not
shown), all of the products observed contained the intact
oligonucleotide (Figure 1d). The fragments corresponding
to cleavage at the 2=-deoxycytidine observed for the ex-
periments with dCT5 described above were completely
absent with dT2CT3. Also, a larger number of adducts of
the intact oligonucleotide were formed, including:
(dT2CT3 4·H 1)
3, (dT2CT3 5·H 2·1)
3, (dT2CT3
3·H 1)2, (dT2CT3 4·H 2·1)
2, and (dT2CT3 5·H
3·1)2.
As before, the more abundant ions in Figure 1d,
including (dT2CT3  4·H)
4 at 436 Th, (dT2CT3 
3·H)3 at 582 Th, (dT2CT3  4·H  1)
3 at 697 Th,
(dT2CT3  5·H  2·1)
3 at 813 Th, 951 Th, (dT2CT3 
3·H  1)2 at 1046 Th, (dT2CT3  4·H  2·1)
2 at 1220
Th, and (dT2CT3  5·H  2·1)
2 at 1392 Th, were
isolated and subjected to CAD for structural character-
ization (Figure 3). In this case, although 3= fragments of
the intact oligonucleotides were again most common, a
fair number of the complementary (a  base) ions were
observed among fragments resulting from both ad-
ducted (Figure 3c, d, f, g, and h) and nonadducted
(Figure 3a and b) oligonucleotides. The position of these
backbone cleavages seemed to have no relation to the
position of 2=-deoxycytidine in the oligonucleotide.
Also, upon dissociation of the 1/dT2CT3 adducts, both
adducted fragment ions (i.e., ones that contain 1) and
non-adducted fragments (i.e., ones without 1) were
generated in similar abundances. That this was consis-tently true regardless of the oligonucleotide sequence
(dT2CT3 versus dCT5) offers further evidence that the
linkage between 1 and the oligonucleotide is at least of
comparable strength to the internal covalent bonds in
the oligonucleotide. CAD of the unassigned ion at 951
Th revealed that this ion contained both intact dT2CT3
and 1.
With both dCT5 and dT2CT3, more than a single
molecule of 1 was observed bound to the oligonucleo-
tide, which implies that despite the preference for
reaction with cytosine previously observed [29], inter-
actions with other sites on the oligonucleotide also
occur. These multiply adducted species clearly cannot
yield much information about the location of the
enediyne, but an examination of the singly-adducted
intact oligonucleotides reveals some clues. From the
experiments with dCT5, the only suitable parent con-
taining a single molecule of 1 was (dCT5  4H  1)
3.
On fragmentation (Figure 2c), it yielded two different w
fragments, w2 and w4, as well as an (a5  base)
fragment that each contained a molecule of 1. Two
possible scenarios can rationalize this behavior. First, 1
could be localized on the 2=-deoxythymine in the fifth
position because it is the only residue contained in all
three of the fragments. An alternative conclusion is that
1 did not localize at a specific site on the oligonucleotide
sequence but, rather, the parent ion was a mixture of
different adducted structures. Additionally, the cleaved
ions in the parent spectrum, dT5
3, (dT5  1)
3, (dT5 
1)2, and (dT5  2·1)
2, also suggest that when 1
interacted with the cytosine it lead to subsequent cleav-
age either before or during the MS analysis.
An analogous intact adduct, (dT2CT3  4·H  1)
3,
along with several other adducts between 1 and
dT2CT3, were also examined. In these CAD mass spec-
tra (Figure 3c, d, f, g, and h), nearly all the observed ions
containing 1 also contained the 2=-deoxycytidine resi-
due. Although it cannot be confirmed whether this
results from localized or random attachment, in this
case there is no apparent reason to discount the possi-
bility of localization at the 2=-deoxycytidine. Also, the
lack of cleaved ions in the ESI mass spectrum observed
for the incubation of dT2CT3 with 1 (Figure 1d) supports
that the 1-induced cleavage at 2=-deoxycytidine pro-
ceeds more readily with 5= as opposed to internal
2=-deoxycytidine residues.
Interactions Between 1 and dCC or dGA
Experiments with the dinucleotide dCC incubated with
1 at pH 6 yielded results indicative of the binding
between the oligonucleotide and 1. In the negative
mode typically used for DNA analysis due to the acidic
phosphate backbone, the overall signal was low; how-
ever, (dCC  1  H) and (dCC  2·1) ions were
detected in addition to the CF3SO3
 counter-ion (Figure
4a). With such a small oligonucleotide, however, the
electrostatics are not necessarily dominated by the
phosphate groups, and positive mode analysis becomes
 2
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present in approximately equal abundance with the
Figure 3. CAD of ions isolated from the mass sp
(a) (dT2CT3  4·H)
4 at 436 Th, (b) (dT2CT3  3
(d) (dT2CT3  5·H  2·1)
3 at 813 Th, (e) 951 Th
4·H  2·1)2 at 1220 Th, and (h) (dT2CT3  5·H(dCC  1  H) ion. Other ions detected at lowerabundances included the (dCC  2·1)2 and (dCC 
2·1) ions.
m of dT2CT3 incubated with 1. Parent ions were
at 582 Th, (c) (dT2CT3  4·H  1)
3 at 697 Th,
dT2CT3  3·H  1)
2 at 1046 Th, (g) (dT2CT3 
·1)2 at 1392 Th.ectru
·H)3
, (f) (On isolation of the (dCC  1) ion, both with and
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phenylethynyl group of 1 and subsequent fragmenta-
tion by CAD, two products related to ejection of 1 from
the oligonucleotide, (dCC  H) and 1, were ob-
served. These species, however, were dwarfed by a
product corresponding to an adduct between 1 and the
cytosine nucleobase (Figure 5a) formed via detachment
of the cytosine nucleobase from the deoxyribose of the
dCC backbone. Likely, the product of a base-loss mech-
anism similar to the fragmentation commonly observed
for CAD of oligonucleotides [36], the presence of this
ion offers strong evidence for covalent attachment of 1
directly to the nucleobase.
To further probe the structure of this adduct, the (C
 1) fragment was then isolated and subjected to a
Figure 4. Mass spectrum of dCC incubated with 1 at pH 6
collected for 50-2000 Th in (a) negative mode and (b) positive
mode. (c) Mass spectrum of dCC incubated with 1 following a
piperidine/heat treatment in the negative mode.second stage of CAD (Figure 5b). An assortment offragments resulted for which proposed structures are
shown in Scheme 1. Through comparing the fragments
observed both with and without the 13C label at posi-
tion 1, it was found that each of the ions shown retained
the label upon fragmentation. For clarity, only the
monoisotopic mass is listed although with the 13C label,
the ions were observed 1 Th greater. As shown in
Scheme 1, the position of the 13C label in the structures
is indicated with a dagger (†). The structures in Scheme
1 are consistent both with the observed m/z values and
the precursor structures. Scheme 1 shows 1 bound to
the 5=-2=-deoxycytidine rather than to the 3= nucleotide.
The ligand could be bound to either nucleotide without
a discernible change in the mass spectra, and thus the 5=
adduct is depicted as one example of the proposed
binding site of the ligand. The most abundant frag-
ments resulted from detachment of the nucleobase
leaving an intact 1 ion at m/z 347 or the loss of a
propynyl benzene yielding the ion at 342 Th. This 342
Th fragment ion along with the ones at 234 and 266 Th
resulting from both the loss of a propynyl benzene and
either the cytosine nucleobase or benzene, respectively,
indicate that the enediyne binds to cytosine through the
ethynyl benzene because attachment to the propynyl
benzene fails to yield reasonable fragment structures for
these masses. Other fragments observed correspond to
losses of various parts of the cytosine nucleobase. One
of these, the fragment at 364 Th, would be difficult to
justify were the cytosine bound through the pyrimidine
nitrogen rather than through the amine.
Since binding to thymine bases was observed for the
longer oligonucleotides discussed earlier, a dinucle-
otide containing adenine and guanine was also studied
to determine binding specificity. Upon incubation of
dGA with 1, a dGA/1 complex was detected by ESI-MS
(data not shown). CAD, including MSn experiments, of
the resulting complexes indicated that 1 bound to either
the guanine or adenine nucleobase.
Piperidine/Heat Treatment of 1 and dCC or dGA
As with the longer oligonucleotides above, dCC sam-
ples were incubated with 1 and then subjected to a
piperidine/heat treatment to initiate cleavage pathways
and further characterize the interaction between 1 and
the cytosine nucleobase. In the positive mode, new
product ions of m/z 432 and 450, corresponding to 1
bound to piperidine or piperidine and water, respec-
tively, in addition to new products of m/z 332 and 749
were observed. The most abundant product ion in the
negative mode for the piperidine/heat treatment of 1
and dCC was observed at m/z 747 (Figure 4c). The ion of
m/z 332 provides considerable insight into how piperi-
dine binds to 1. Isolation and dissociation of this ion
confirms that the piperidine is bound to the propynyl
benzene arm of 1, thus indicating that the cytosine
binds to the other arm (ethynyl benzene arm) of 1. No
cleavage products were seen in either the positive or
negative ESI mass spectra. Due to the low masses of
1349J Am Soc Mass Spectrom 2006, 17, 1342–1352 ENEDIYNE-DNA ADDUCT EVALUATED BY ESI-MSpossible cleavage products, products from piperidine
induced cleavage could have inadvertently been lost
during the ZipTip purification step.
The CAD mass spectra of the product ions of m/z 747
(negative) and m/z 749 (positive) are shown in Figure 5c
and d, with substantial overlap between the two spec-
tra. A proposed structure of the product generated
upon the piperidine/heat treatment of (dCC  1) is
shown in (Structure 2), along with assignments of the
fragment ions resulting upon CAD of this product in
the negative ion mode. For the m/z 747 precursor ion,
the most abundant fragment ion results from the loss of
the cytosine nucleobase, yielding the ion of m/z 636.
Another abundant fragment ion of m/z 472 corresponds
to a cleaved portion of dCC. The fragment ion of m/z
343 corresponds to (C  1  propynyl benzene) and
confirms that 1 attaches to the 2=-deoxycytidine residue
through the ethynyl benzene arm. For the m/z 749
precursor ion, the most abundant fragment ion of m/z
344 corresponds to the cytosine nucleobase bound to
the ethynyl benzene and fused ring of 1. Other less
abundant fragment ions result from the loss of dCC,
resulting in the fragment ion of m/z 233, and from the
loss of the deoxyribonucleoside, yielding the fragment
ion of m/z 539. While the fragmentation patterns of m/z
747 and 749 indicated that these ions are not the result
Figure 5. Tandem mass spectra of products ion
with 1 followed by a piperidine/heat treatment (
(MS3 of (C 1) at 458 Th from the spectrum in
and (d) CAD of m/z 749 from positive mode
piperidine/heat treatment.of piperidine induced backbone cleavage, they areconsistent with a product structure in which dCC is
bound to the ethynyl benzene arm of 1, which supports
the proposed attachment site.
To evaluate the specificity of cleavage, the incubate
of dGA and 1 was also subjected to the piperidine/heat
treatment. There was no evidence of cleavage of [dGA
 1], and the dinucleotide was the most abundant ion in
the negative mode mass spectrum (data not shown).
While 1 clearly can bind to nucleotides other than
2=-deoxycytidine, the piperidine-induced cleavage ap-
pears to be specific for the cytosine nucleobase.
Conclusions
Electrospray ionization mass spectrometric analysis of
carefully selected oligonucleotides incubated with the
novel enediyne ligand 1 revealed several types of
important clues about the interactions between 1 and
DNA. First, 1 readily formed adducts of various stoi-
chiometries with dC8 consistent with previous observa-
tions [29], and the mass analysis confirmed a direct
interaction not mediated by metals or other com-
pounds. Collisionally activated dissociation of these
adducts revealed that, in many cases, both ejection of
the ligand and DNA backbone cleavages occurred to
similar extents, indicating that the interaction between 1
dCC incubated with 1 (a) and (b, or incubated
d (d). (a) CAD of (dCC 1) at 863 Th. (b) CAD
) CAD of m/z 747 from negative mode spectrum
ctrum of dCC incubated with 1 followed bys from
c) an
(a). (c
speand DNA is of comparable strength to the bonds in the
mentation pathway of (dCC  1).
1350 SHERMAN ET AL. J Am Soc Mass Spectrom 2006, 17, 1342–1352oligonucleotide and suggesting that the DNA-1 adduct
forms through a covalent linkage.
From a comparison of the interactions of 1with dCT5
and dT2CT3 it became apparent that the extent of
2=-deoxycytidine-specific backbone cleavage induced
by 1 varied significantly with the DNA sequence. When
reacted under identical conditions, extensive cleavage
of dCT5 adjacent to the 2=-deoxycytidine was observed
in the mass spectrum, while only the intact oligonucle-
otide was observed for dT2CT3. Also, for both se-
quences extensive adduction of 1 was observed.
Lastly, evaluation of adducts formed between 1 and
the dinucleotide dCC provided strong evidence for
attachment of the enediyne directly to the cytosine
nucleobase. Additional CAD studies of the cytosine-1
adduct provided an array of fragment ions consistent
with the adduct forming through nucleophilic attack of
CH
H
N
N+
HO
N
ON
O
HO
HH
HH
PO
OH
O
N
NH2
ON
O
HOH
HH
HH
HN
CH
N+
N
N+
N
863 Th
4
234 Th
NH
HN
CH
N+
N
NH
HN
CH
N+
N
NH
HN
CH
N+
N
390 Th
224 Th
415 Th
Scheme 1. Proposed CAD fragHN
CH
N+
N
N
C
N+
N
N
ON
H
HN
CH
58 Th
347 Th
390 Th
364 Th
H2N
CH
N+
N
C
NH+
N
N N
HN
O
NH+
N
N N
HN
O
266 Th
342 Ththe ethynyl benzene of 1 by the cytosine amino group.HO
N
ON
O
HO
HH
HH
PO O
N
NH2
ON
O
HOH
HH
HH
HN
CH
N
N
O-
m/z 747
343-
636-
472-Structure 2
1351J Am Soc Mass Spectrom 2006, 17, 1342–1352 ENEDIYNE-DNA ADDUCT EVALUATED BY ESI-MSAcknowledgments
The authors gratefully acknowledge support from the Robert A.
Welch Foundation (F-1155) and NIH (RO1 GM65956).
References
1. Edo, K.; Mizugaki, M.; Koide, Y.; Seto, H.; Furihata, K.; Otake, N.;
Ishida, N. The Structure of Neocarzinostatin Chromophore Possessing a
Novel Bicyclo[7,3,0]dodecadiyne System. Tetrahedron Lett. 1985, 26,
331–334.
2. Nicolaou, K. C.; Dai, W.-M. Chemistry and Biology of the Enediyne
Anticancer Antibiotics. Angew. Chem. Int. Ed. Eng. 1991, 30, 1387–1416.
3. Nicolaou, K. C.; Smith, A. L.; Yue, E. W. Chemistry and Biology of
Natural and Designed Enediynes. Proc. Natl. Acad. Sci. U.S.A. 1993, 90,
5881–5888.
4. Smith, A. L.; Nicolaou, K. C. The Enediyne Antibiotics. J. Med. Chem.
1996, 39, 2103–2117.
5. Galm, U.; Hager, M. H.; Van Lanen, S. G.; Ju, J.; Thorson, J. S.; Shen, B.
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin. Chem.
Rev. 2005, 105, 739–758.
6. Lee, M. D.; Dunne, T. S.; Siegel, M. M.; Chang, C. C.; Morton, G. O.;
Borders, D. B. Calichemicins, a Novel Family of Antitumor Antibiotics.
I. Chemistry and Partial Structure of Calichemicin 1
I . J. Am. Chem. Soc.
1987, 109, 3464–3466.
7. Lee, M. D.; Dunne, T. S.; Chang, C. C.; Ellestad, G. A.; Siegel, M. M.;
Morton, G. O.; McGahren, W. J.; Borders, D. B. Calichemicins, a Novel
Family of Antitumor Antibiotics. II. Chemistry and Structure of Cali-
chemicin 1
I . J. Am. Chem. Soc. 1987, 109, 3466–3468.
8. Konishi, M.; Ohkuma, H.; Matsumoto, K.; Tsuno, T.; Kamei, H.; Miyaki,
T.; Oki, T.; Kawaguchi, H.; VanDuyne, G. D.; Clardy. J. Dynemicin A, a
Novel Antibiotic with the Anthraquinone and 1,5-Diyn-3-ene Subunit. J.
Antibiot. 1989, 42, 1449–1452.
9. Golik, J.; Clardy, J.; Dubay, G.; Groenewold, G.; Kawaguchi, H.;
Konishi, M.; Krishnan, B.; Ohkuma, H.; Saitoh, K.; Doyle, T. W.
Esperamicins, a Novel Class of Potent Antitumor Antibiotics. II. Struc-
ture of Esperamicin X. J. Am. Chem. Soc. 1987, 109, 3461–3462.
10. Golik, J.; Dubay, G.; Groenewold, G.; Kawaguchi, H.; Konishi, M.;
Krishnan, B.; Ohkuma, H.; Saitoh, K.; Doyle, T. W. Esperamicins, a
Novel Class of Potent Antitumor Antibiotics. III. Structure of Esperam-
icins A1, A2, and A1b. J. Am. Chem. Soc. 1987, 109, 3462–3464.
11. Jones, G. B.; Fouad, F. S. Designed Enediyne Antitumor Agents. Curr.
Pharm. Des. 2002, 8, 2415–2440.
12. Klein, M.; Walenzyk, T.; König, B. Electronic Effects on the Bergman
Cyclization of Enediynes. A Review.Collect. Czech. Chem. Commun. 2004,
69, 945–965.
13. McPhee, M. M.; Kerwin, S. M. Synthesis and Metal Ion Binding Studies
of Enediyne-Containing Crown Ethers. J. Org. Chem. 1996, 61, 9385–
9393.
14. Jones, G. B.; Wright, J. M.; Rush, T. M.; Plourde, G. W., II; Kelton, T. F.;
Mathews, J. E.; Huber, R. S.; Davidson, J. P. Facile Unmasking of
Dicobalt Hexacarbonyl Complexes of 1-Cyclodecene-3,9-Diynes
(Enediynes). J. Org. Chem. 1997, 62, 9379–9381.
15. Dai, W.-M.; Lai, K. W.; Wu, A.; Hamaguchi, W.; Lee, M. Y. H.; Zhou, L.;
Ishii, A.; Nishimoto, S. DNA. Cleavage Potency, Cytotoxicity, and
Mechanism of Action of a Novel Class of Enediyne Prodrugs. J. Med.
Chem. 2002, 45, 758–761.
16. Banfi, L.; Guanti, G. Synthesis of Intramolecularly Activated
Lactenediynes and the Evaluation of Their Activity Against Plasmid
DNA. Eur. J. Org. Chem. 2002, 22, 3745–3755.
17. Schmittel, M.; Viola, G.; Dall’Acqua, F.; Morbach, G. A Novel Concept
to Activate Enediynes for DNA Cleavage. Chem. Commun. 2003, 5,
646–647.
18. Guanti, G.; Riva, R. Simplified Dynemicin Analogs: Diastereoselective
Synthesis and Evaluation of Their Activity Against Plasmid DNA. Org.
Biomol. Chem. 2003, 1, 3967–3976.
19. Suzuki, I.; Shigenaga, A.; Nemoto, H.; Shibuya, M. Synthesis and DNA
Damaging Ability of Enediyne-Polyamine Conjugates. Tetrahedron Lett.
2004, 45, 1955–1959.
20. Usuki, T.; Inoue, M.; Hirama, M.; Tanaka, T. Rational Design of a Supra
C-1027: Kinetically Stabilized Analog of the Antitumor Enediyne Chro-
moprotein. J. Am. Chem. Soc. 2004, 126, 3022–3023.
21. Suzuki, I.; Uno, S.; Tsuchiya, Y.; Shigenaga, A.; Hisao, N.; Shibuya, M.
Synthesis and DNA Damaging Ability of Enediyne Model Compounds
Possessing Photo-Triggering Devices. Bioorg. Med. Chem. Lett. 2004, 14,
2959–2962.
22. Fouad, F. S.; Crasto, C. F.; Lin, Y.; Jones, G. B. Photoactivated Enediynes:
Targeted Chimeras which Undergo Photo-Bergman Cyclization. Tetra-
hedron. Lett. 2004, 45, 7753–7756.
23. Basak, A.; Roy, S. K.; Mandal, S. Activation of Macrocyclic Enediynes by
Transannular Cyclization. Angew. Chem. Int. Ed. 2005, 44, 132–135.
24. Boger, D. L.; Zhou, J. CDPI. 3-Enediyne and CDPI3-EDTA Conjugates:
A New Class of DNA Cleaving Agents. J. Org. Chem. 1993, 58,
3018–3024.25. Toshima, K.; Ohta, K.; Ohashi, A.; Nakamura, T.; Nakata, M.; Mat-
sumura, S. Design, Synthesis, and DNA Cleaving Profiles of HybridsContaining the Novel Enediyne and Naturally Occurring DNA
Intercalators. J. Chem. Soc. Chem. Commun. 1993, 1525–1527.
26. Tokuda, M.; Fujiwara, K.; Gomibuchi, T.; Hirama, M.; Uesugi, M.;
Sugiura, Y. Synthesis of a Hybrid Molecule Containing Neocarzinosta-
tin Chromophore Analog and Minor Groove Binder. Tetrahedron. Lett.
1993, 34, 669–672.
27. David, W. M.; Kumar, D.; Kerwin, S. M. Synthesis of a Heterocyclic
Aza-Enediyne and Its DNA-Cleavage Properties. Bioorg. Med. Chem.
Lett. 2000, 10, 2509–2512.
28. Kumar, D.; David, W. M.; Kerwin, S. M. N-Propargyl-2-alkynylbenzo-
thiazolium Aza-Enediynes: Role of the 2-Alkynylbenzothiazolium
Functionality in DNA Cleavage. Bioorg. Med. Chem. Lett. 2001, 11,
2971–2974.
29. Tuntiwechapikul, W.; David, W. M.; Kumar, D.; Salazar, M.; Kerwin,
S. M. DNA. Modification by 4-aza-3-ene-1,6-diynes: DNA Cleavage,
pH-Dependent Cytosine-Specific Interactions, and Cancer Cell Cytotox-
icity. Biochemistry 2002, 41, 5283–5290.
30. Sinha, S. C.; Li, L.-S.; Miller, G. P.; Dutta, S.; Rader, C.; Lerner, R. A.
Prodrugs of Dynemicin Analogs for Selective Chemotherapy Mediated
by an Aldolase Catalytic Ab. Proc. Natl. Acad. Sci. U.S.A. 2004, 101,
3095–3099.
31. Liebisch, G.; Drobnik, W.; Lieser, B.; Schmitz, G. High-Throughput
Quantification of Lysophosphatidylcholine by Electrospray Ionization
Tandem Mass Spectrometry. Clin. Chem. 2002, 48, 2217–2224.
32. Gooding, K. B.; Higgs, R.; Hodge, B.; Stauffer, E.; Heinz, B.; McKnight,
K.; Philpps, K.; Shapiro, M.; Winkler, M.; Ng, W.-L.; Julian, R. K. High
Throughput Screening of Library Compounds Against an Oligonucle-
otide Substructure of an RNA Target. J. Am. Soc. Mass Spectrom. 2004, 15,
884–892.
33. Qian, J.; Voorbach, M. J.; Huth, J. R.; Coen, M. L.; Zhang, H.; Ng, S.-C.;
Comess, K. M.; Petros, A. M.; Rosenberg, S. H.; Warrior, U.; Burns, D. J.
Discovery of Novel Inhibitors of Bcl-xL Using Multiple High-Throughput
Screening Platforms. Anal. Biochem. 2004, 328, 131–138.
34. Limbach, P. A. Indirect Mass Spectrometric Methods for Characterizing
and Sequencing Oligonucleotides.Mass Spectrom. Rev. 1996, 15, 297–336.
35. Nordhoff, E.; Kirpekar, F.; Roepstorff, P. Mass Spectrometry of Nucleic
Acids. Mass Spectrom. Rev. 1996, 15, 67–138.
36. McLuckey, S. A.; Van Berkel, G. J.; Glish, G. L. Tandem Mass Spectrom-
etry of Small Multiply Charged Oligonucleotides. J. Am. Soc. Mass
Spectrom. 1992, 3, 60–70.
37. Beck, J. L.; Colgrave, M. L.; Ralph, S. F.; Sheil, M. M. Electrospray
Ionization Mass Spectrometry of Oligonucleotide Complexes with
Drugs, Metals, and Proteins. Mass Spectrom. Rev. 2001, 20, 61–87.
38. Hofstadler, S. A.; Griffey, R. H. Analysis of Noncovalent Complexes of
DNA and RNA by Mass Spectrometry. Chem. Rev. 2001, 101, 377–390.
39. Van den Driessche, B.; Lemiere, F.; Van Dongen, W.; Esmans, E. L.
Structural Characterization of Melphalan Modified 2=-Oligode-
oxynucleotides by Miniaturized LC-ES MS/MS. J. Am. Soc. Mass Spec-
trom. 2004, 15, 568–579.
40. Iannitti, P.; Sheil, M. M.; Wickham, G. High Sensitivity and Fragmen-
tation Specificity in the Analysis of Drug-DNAAdducts by Electrospray
Tandem Mass Spectrometry. J. Am. Chem. Soc. 1997, 119, 1490–1491.
41. Richter, S. N.; Menegazzo, I.; Fabris, D.; Palumbo, M. Concerted
bis-Alkylating Reactivity of Clerocidin Towards Unpaired Cytosine
Residues in DNA. Nucleic Acids Res. 2004, 32, 5658–5667.
42. Harsch, A.; Marzilli, L. A.; Bunt, R. C.; Stubbe, J.; Vouros, P. Accurate
and Rapid Modeling of Iron-Bleomycin-Induced DNA Damage Using
Tethered Duplex Oligonucleotides and Electrospray Ionization Ion Trap
Mass Spectrometric Analysis. Nucleic Acids Res. 2000, 28, 1978–1985.
43. Hoes, I.; Van Dongen, W.; Lemiere, F.; Esmans, E. L.; Van Bockstaele, D.;
Berneman, Z. N. Comparison Between Capillary and Nano Liquid
Chromatography-Electrospray Mass Spectrometry for the Analysis of
Minor DNA-Melphalan Adducts. J. Chromatogr. B Anal. Technol. Biomed.
Life Sci. 2000, 748, 197–212.
44. Balcome S.; Park S.; Quirk Dorr, D. R.; Hafner, L.; Phillips, L.; Tretya-
kova, N. Adenine-Containing. DNA-DNA Cross-Links of Antitumor
Nitrogen Mustards. Chem. Res. Toxicol. 2004, 17, 950–962.
45. Wang, Y.; Zhang, Q.; Wang, Y. Tandem Mass Spectrometry for the
Determination of the Sites of DNA Interstrand Cross-Link. J. Am. Soc.
Mass Spectrom. 2004, 15, 1565–1571.
46. Wang, Y.; Wang, Y. Structure Elucidation of DNA Interstrand Cross-
Link by a Combination of Nuclease p1 Digestion with Mass Spectrom-
etry. Anal. Chem. 2003, 75, 6306–6313.
47. Franska, M.; Franski, R.; Schroeder, G.; Springer, A.; Beck, S.; Linscheid,
M. Electrospray Ionization Mass Spectrometric Study of Purine Base-
Cisplatin Complexes. Rapid Commun. Mass Spectrom. 2005, 19, 970–974.
48. Gupta, R.; Beck, J. L.; Sheil, M. M.; Ralph, S. F. Identification of
Bifunctional GA and AG Intrastrand Cross-Links Formed Between
Cisplatin and DNA. J. Inorg. Biochem. 2005, 9, 552–559.
49. Warnke, U.; Rappel, C.; Meier, H.; Kloft, C.; Galanski, M.; Hartinger,
C. G.; Keppler, B. K.; Jaehde, U. Analysis of Platinum Adducts with
DNA Nucleotides and Nucleosides by Capillary Electrophoresis Cou-
pled to ESI-MS: Indications of Guanosine 5=-Monophosphate O6-N7
Chelation. Chem. Biochem. 2004, 5, 1543–1549.
50. Gupta, R.; Kapur, A.; Beck, J. L.; Sheil, M. M. Positive Ion Electrospray
Ionization Mass Spectrometry of Double-Stranded DNA/Drug Complexes.
Rapid Commun. Mass Spectrom. 2001, 15, 2472–2480.
51. Kung, A.; Strickmann, D. B.; Galanski, M.; Keppler, B. K. Comparison of
the Binding Behavior of Oxaliplatin, Cisplatin, and Analogs to 5=-GMP
in the Presence of Sulfur-Containing Molecules by Means of Capillary
1352 SHERMAN ET AL. J Am Soc Mass Spectrom 2006, 17, 1342–1352Electrophoresis and Electrospray Mass Spectrometry. J. Inorg. Biochem.
2001, 86, 691–698.
52. Sturla, S. J.; Scott, J.; Lao, Y.; Hecht, S. S.; Villalta, P. W. Mass
Spectrometric Analysis of Relative Levels of Pyridyloxobutylation Ad-
ducts Formed in the Reaction of DNA with a Chemically Activated
Form of the Tobacco-Specific Carcinogen 4-(methylnitrosamino)-1-(3-
pyridyl)-1-Butanone. Chem. Res. Toxicol. 2005, 18, 1048–1055.
53. Borges, C.; Lemiere, F.; Embrechts, J.; van Dongen, W.; Esmans, E. L.
Characterization of Estrone-Nucleic Acid Adducts Formed by Reaction
of 3,4-Estrone-o-Quinone with 2=-Deoxynucleosides/Deoxynucleotides
Using Capillary Liquid Chromatography/Electrospray Ionization Mass
Spectrometry. Rapid Commun. Mass Spectrom. 2004, 18, 2191–2200.
54. Colgrave, M. L.; Iannitti-Tito, P.; Wickham, G.; Sheil, M. M. Rapid
Determination of Sequence Selectivity and Stability of Alkylated Oligo-
nucleotide Adducts by Electrospray Tandem Mass Spectrometry. Aust.
J. Chem. 2003, 56, 401–413.55. Inagaki, S.; Esaka, Y.; Deyashiki, Y.; Sako, M.; Goto, M. Analysis of DNA
Adducts of Acetaldehyde by Liquid Chromatography-Mass Spectrom-
etry. J. Chromatogr. A 2003, 987, 341–347.
56. Little, D. P.; Chorush, R. A.; Speir, J. P.; Senko, M. W.; Kelleher, N. L.;
McLafferty, F. W. Rapid Sequencing of Oligonucleotides by High-
Resolution Mass Spectrometry. J. Am. Chem. Soc. 1994, 116, 4893–4897.
57. Little, D. P.; Speir, J. P.; Senko, M. W.; O’Connor, P. B.; McLafferty, F. W.
Infrared Multiphoton Dissociation of Large Multiply Charged Ions for
Biomolecule Sequencing. Anal. Chem. 1994, 66, 2809–2815.
58. Keller, K. M.; Brodbelt, J. S. Collisionally Activated Dissociation and
Infrared Multiphoton Dissociation of Oligonucleotides in a Quadrupole
Ion Trap. Anal. Biochem. 2004, 326, 200–210.
59. Schultz, K. N.; Håkansson, K. Rapid Electron Capture Dissociation of
Mass-Selectively Accumulated Oligodeoxynucleotide Dications. Int. J.
Mass Spectrom. 2004, 234, 123–130.
